                         SEQUENCE LISTING

<110>  Pfizer Inc.
       Rinat Neuroscience Corp.
       DUSHIN, Russell George
       STROP, Pavel
       DORYWALSKA, Magdalena
       MOINE, Ludivine
 
<120>  STABILITY-MODULATING LINKERS FOR USE WITH ANTIBODY DRUG 
       CONJUGATES

<130>  PC72108A

<150>  62/042,901
<151>  2014-08-28

<160>  37    

<170>  PatentIn version 3.5

<210>  1
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Construct

<400>  1

Leu Leu Gln Gly Gly 
1               5   


<210>  2
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Construct

<400>  2

Leu Leu Gln Gly 
1               


<210>  3
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Construct

<400>  3

Leu Ser Leu Ser Gln Gly 
1               5       


<210>  4
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Construct

<400>  4

Gly Gly Gly Leu Leu Gln Gly Gly 
1               5               


<210>  5
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Construct

<400>  5

Gly Leu Leu Gln Gly 
1               5   


<210>  6
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Construct

<400>  6

Gly Ser Pro Leu Ala Gln Ser His Gly Gly 
1               5                   10  


<210>  7
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Construct

<400>  7

Gly Leu Leu Gln Gly Gly Gly 
1               5           


<210>  8
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Construct

<400>  8

Gly Leu Leu Gln Gly Gly 
1               5       


<210>  9
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Construct

<400>  9

Gly Leu Leu Gln 
1               


<210>  10
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Construct

<400>  10

Leu Leu Gln Leu Leu Gln Gly Ala 
1               5               


<210>  11
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Construct

<400>  11

Leu Leu Gln Gly Ala 
1               5   


<210>  12
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Construct

<400>  12

Leu Leu Gln Tyr Gln Gly Ala 
1               5           


<210>  13
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Construct

<400>  13

Leu Leu Gln Gly Ser Gly 
1               5       


<210>  14
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Construct

<400>  14

Leu Leu Gln Tyr Gln Gly 
1               5       


<210>  15
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Construct

<400>  15

Leu Leu Gln Leu Leu Gln Gly 
1               5           


<210>  16
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Construct

<400>  16

Ser Leu Leu Gln Gly 
1               5   


<210>  17
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Construct

<400>  17

Leu Leu Gln Leu Gln 
1               5   


<210>  18
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Construct

<400>  18

Leu Leu Gln Leu Leu Gln 
1               5       


<210>  19
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Construct

<400>  19

Leu Leu Gln Gly Arg 
1               5   


<210>  20
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Construct

<400>  20

Leu Leu Gln Gly Pro Pro 
1               5       


<210>  21
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Construct

<400>  21

Leu Leu Gln Gly Pro Ala 
1               5       


<210>  22
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Construct

<400>  22

Gly Gly Leu Leu Gln Gly Pro Pro 
1               5               


<210>  23
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Construct

<400>  23

Gly Gly Leu Leu Gln Gly Ala 
1               5           


<210>  24
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Construct

<400>  24

Leu Leu Gln Gly Ala 
1               5   


<210>  25
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Construct

<400>  25

Leu Leu Gln Gly Pro Gly Lys 
1               5           


<210>  26
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Construct

<400>  26

Leu Leu Gln Gly Pro Gly 
1               5       


<210>  27
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Construct

<400>  27

Leu Leu Gln Gly Pro 
1               5   


<210>  28
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Construct

<400>  28

Leu Leu Gln Pro 
1               


<210>  29
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Construct

<400>  29

Leu Leu Gln Pro Gly Lys 
1               5       


<210>  30
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Construct

<400>  30

Leu Leu Gln Ala Pro Gly Lys 
1               5           


<210>  31
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Construct

<400>  31

Leu Leu Gln Gly Ala Pro Gly 
1               5           


<210>  32
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Construct

<400>  32

Leu Leu Gln Gly Ala Pro 
1               5       


<210>  33
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Construct

<400>  33

Leu Leu Gln Gly Pro Ala 
1               5       


<210>  34
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Construct

<400>  34

Leu Leu Gln Gly Pro Pro 
1               5       


<210>  35
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Construct

<400>  35

Gly Gly Leu Leu Gln Gly Pro Pro 
1               5               


<210>  36
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Construct

<400>  36

Leu Leu Gln Leu Gln Gly 
1               5       


<210>  37
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Construct


<220>
<221>  misc_feature
<222>  (1)..(2)
<223>  Xaa = Leu, Ala, Gly, Ser, Val, Phe, Tyr, His, Arg, Asn, Glu, Asp,
       Cys, Gln, Ile, Met, Pro, Thr, Lys, or Trp

<220>
<221>  misc_feature
<222>  (4)..(4)
<223>  Xaa = Leu, Ala, Gly, Ser, Val, Phe, Tyr, His, Arg, Asn, Glu, Asp,
       Cys, Gln, Ile, Met, Pro, Thr, Lys, or Trp

<400>  37

Xaa Xaa Gln Xaa 
1               


